{"transactions":[{"id":746196,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-08T20:15:14.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":11580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 5, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11580},"source":{"system":"sec-edgar","filing":"0001674278-26-000002","document":"form4-06082026_040603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000167427826000002/form4-06082026_040603.xml","form_type":"4"}},{"id":746195,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-08T20:15:14.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":10987,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest in one installment on June 4, 2027, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest in one installment on June 4, 2027, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy."}],"balance_after":10987,"derivative":{"underlying":"Common Stock","underlying_shares":10987},"source":{"system":"sec-edgar","filing":"0001674278-26-000002","document":"form4-06082026_040603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000167427826000002/form4-06082026_040603.xml","form_type":"4"}},{"id":746194,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-08T20:15:14.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":42350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 4, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan, or the Plan) through each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy."}],"balance_after":42350,"derivative":{"exercise_price":4.71,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":42350},"source":{"system":"sec-edgar","filing":"0001674278-26-000002","document":"form4-06082026_040603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000167427826000002/form4-06082026_040603.xml","form_type":"4"}},{"id":746193,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-08T20:15:14.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":11580,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":45105,"source":{"system":"sec-edgar","filing":"0001674278-26-000002","document":"form4-06082026_040603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000167427826000002/form4-06082026_040603.xml","form_type":"4"}},{"id":1117883,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-09T20:20:18.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":false,"shares":4793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 6, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4793},"source":{"system":"sec-edgar","filing":"0001415889-25-016249","document":"form4-06092025_040606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000141588925016249/form4-06092025_040606.xml","form_type":"4"}},{"id":1117882,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-09T20:20:18.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":11580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest in one installment on June 5, 2026, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest in one installment on June 5, 2026, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy."}],"balance_after":11580,"derivative":{"underlying":"Common Stock","underlying_shares":11580},"source":{"system":"sec-edgar","filing":"0001415889-25-016249","document":"form4-06092025_040606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000141588925016249/form4-06092025_040606.xml","form_type":"4"}},{"id":1117881,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:20:18.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":42350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 5, 2025, subject to the Reporting Person's Continuous Service (as defined in the Plan) through each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy."}],"balance_after":42350,"derivative":{"exercise_price":1.56,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":42350},"source":{"system":"sec-edgar","filing":"0001415889-25-016249","document":"form4-06092025_040606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000141588925016249/form4-06092025_040606.xml","form_type":"4"}},{"id":1117880,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T20:20:18.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":true,"shares":4793,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":33525,"source":{"system":"sec-edgar","filing":"0001415889-25-016249","document":"form4-06092025_040606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000141588925016249/form4-06092025_040606.xml","form_type":"4"}},{"id":1472064,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T20:15:13.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 20, 2025, subject to the Reporting Person's continuous service as of such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.15,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001415889-24-017822","document":"form4-06212024_040609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000141588924017822/form4-06212024_040609.xml","form_type":"4"}},{"id":1484940,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-10T20:15:21.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":4793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 6, 2025, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 6, 2025, subject to the Reporting Person's continuous service through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This grant was made pursuant to the issuer's ninth amended and restated non-employee director compensation policy."}],"balance_after":4793,"derivative":{"underlying":"Common Stock","underlying_shares":4793},"source":{"system":"sec-edgar","filing":"0001415889-24-016197","document":"form4-06102024_040613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000141588924016197/form4-06102024_040613.xml","form_type":"4"}},{"id":1484939,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T20:15:21.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":15750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in twelve equal monthly installments commencing July 6, 2024, subject to Reporting Person's continuous service through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This grant was made pursuant to the issuer's ninth amended and restated non-employee director compensation policy."}],"balance_after":15750,"derivative":{"exercise_price":1.03,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":15750},"source":{"system":"sec-edgar","filing":"0001415889-24-016197","document":"form4-06102024_040613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000141588924016197/form4-06102024_040613.xml","form_type":"4"}},{"id":1492317,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-04T20:30:16.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":false,"shares":4660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying these restricted stock units vested on June 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying these restricted stock units vested on June 1, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4660},"source":{"system":"sec-edgar","filing":"0001415889-24-015364","document":"form4-06042024_040610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000141588924015364/form4-06042024_040610.xml","form_type":"4"}},{"id":1492316,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T20:30:16.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":true,"shares":4660,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":28732,"source":{"system":"sec-edgar","filing":"0001415889-24-015364","document":"form4-06042024_040610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000141588924015364/form4-06042024_040610.xml","form_type":"4"}},{"id":1774654,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-09-22T20:35:39.000Z","date":"2023-09-22","kind":"exercise","planned":false,"acquired":false,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.4,"expiration_date":"2023-10-16","underlying":"Common Stock","underlying_shares":22727},"source":{"system":"sec-edgar","filing":"0001209191-23-050381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919123050381/doc4.xml","form_type":"4"}},{"id":1774653,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-22T20:35:39.000Z","date":"2023-09-22","kind":"exercise","planned":false,"acquired":true,"shares":22727,"price":0.4,"value":9090.8,"ownership":{"direct":true},"balance_after":51040,"source":{"system":"sec-edgar","filing":"0001209191-23-050381","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919123050381/doc4.xml","form_type":"4"}},{"id":1833137,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true}}],"security":"SSKN Common Stock","published_at":"2023-07-07T16:06:43.000Z","date":"2023-07-05","kind":"grant","planned":false,"acquired":true,"shares":36408,"price":1.03,"value":37500.24,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Restricted Stock Units issued to the recipient in lieu of a portion of the recipient's Board Compensation on July 5, 2023, utilizing the closing price on July 3, 2023.  The Restricted Stock will vest at 100%, in equal quarterly installments, over a 12 month period."}],"balance_after":109724,"source":{"system":"sec-edgar","filing":"0001051514-23-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000105151423000029/form4.xml","form_type":"4"}},{"id":1845219,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T20:38:58.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2024, subject to the Reporting Person's continuous service as of such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.31,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-039421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919123039421/doc4.xml","form_type":"4"}},{"id":1867104,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-05T21:12:17.000Z","date":"2023-06-02","kind":"exercise","planned":false,"acquired":false,"shares":4507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 2, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4507},"source":{"system":"sec-edgar","filing":"0001209191-23-034477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919123034477/doc4.xml","form_type":"4"}},{"id":1867103,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-05T21:12:17.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":4660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant was made pursuant to the issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 1, 2024, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 1, 2024, subject to the Reporting Person's continuous service through such date."}],"balance_after":4660,"derivative":{"underlying":"Common Stock","underlying_shares":4660},"source":{"system":"sec-edgar","filing":"0001209191-23-034477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919123034477/doc4.xml","form_type":"4"}},{"id":1867102,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-05T21:12:17.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":15750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant was made pursuant to the issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option will vest in twelve equal monthly installments commencing July 1, 2023, subject to Reporting Person's continuous service through each such date."}],"balance_after":15750,"derivative":{"exercise_price":8.7,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":15750},"source":{"system":"sec-edgar","filing":"0001209191-23-034477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919123034477/doc4.xml","form_type":"4"}},{"id":1867101,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T21:12:17.000Z","date":"2023-06-02","kind":"exercise","planned":false,"acquired":true,"shares":4507,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":24072,"source":{"system":"sec-edgar","filing":"0001209191-23-034477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919123034477/doc4.xml","form_type":"4"}},{"id":1885194,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-19T16:18:07.000Z","date":"2023-05-19","kind":"exercise","planned":false,"acquired":false,"shares":2538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2538},"source":{"system":"sec-edgar","filing":"0001169245-23-000031","document":"wf-form4_168452745624931.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924523000031/wf-form4_168452745624931.xml","form_type":"4"}},{"id":1885193,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T16:18:07.000Z","date":"2023-05-19","kind":"exercise","planned":false,"acquired":true,"shares":2538,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."}],"balance_after":2538,"source":{"system":"sec-edgar","filing":"0001169245-23-000031","document":"wf-form4_168452745624931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924523000031/wf-form4_168452745624931.xml","form_type":"4"}},{"id":2222053,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:22:55.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2023."}],"balance_after":30000,"derivative":{"exercise_price":1.62,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-039222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919122039222/doc4.xml","form_type":"4"}},{"id":2236457,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-10T16:20:34.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":2538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed to correct an error in the total Stock Options and RSUs acquired by the Reporting Person. All other information set forth in the May 20, 2022 Form 4 remains correct."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."}],"balance_after":2538,"derivative":{"underlying":"Common Stock","underlying_shares":2538},"source":{"system":"sec-edgar","filing":"0001169245-22-000081","document":"wf-form4a_165489241494222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000081/wf-form4a_165489241494222.xml","form_type":"4/A","original_submission_date":"2022-05-20"}},{"id":2236456,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2022-06-10T16:20:34.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":11842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed to correct an error in the total Stock Options and RSUs acquired by the Reporting Person. All other information set forth in the May 20, 2022 Form 4 remains correct."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."}],"balance_after":11842,"derivative":{"exercise_price":0.8419,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":11842},"source":{"system":"sec-edgar","filing":"0001169245-22-000081","document":"wf-form4a_165489241494222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000081/wf-form4a_165489241494222.xml","form_type":"4/A","original_submission_date":"2022-05-20"}},{"id":2242378,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-06T21:18:50.000Z","date":"2022-06-03","kind":"exercise","acquired":false,"shares":3356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 3, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3356},"source":{"system":"sec-edgar","filing":"0001209191-22-034585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919122034585/doc4.xml","form_type":"4"}},{"id":2242377,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-06T21:18:50.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":4507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date."}],"balance_after":4507,"derivative":{"underlying":"Common Stock","underlying_shares":4507},"source":{"system":"sec-edgar","filing":"0001209191-22-034585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919122034585/doc4.xml","form_type":"4"}},{"id":2242376,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-06T21:18:50.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":15750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option will vest in twelve equal monthly installments commencing July 2, 2022, subject to Reporting Person's continuous service through each such date."}],"balance_after":15750,"derivative":{"exercise_price":14.48,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":15750},"source":{"system":"sec-edgar","filing":"0001209191-22-034585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919122034585/doc4.xml","form_type":"4"}},{"id":2242375,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-06T21:18:50.000Z","date":"2022-06-03","kind":"exercise","acquired":true,"shares":3356,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":19565,"source":{"system":"sec-edgar","filing":"0001209191-22-034585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919122034585/doc4.xml","form_type":"4"}},{"id":2262230,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-20T16:46:36.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001169245-22-000066","document":"wf-form4_165307957678194.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000066/wf-form4_165307957678194.xml","form_type":"4"}},{"id":2262229,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2022-05-20T16:46:36.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."}],"balance_after":17500,"derivative":{"exercise_price":0.8419,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001169245-22-000066","document":"wf-form4_165307957678194.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000066/wf-form4_165307957678194.xml","form_type":"4"}},{"id":2316904,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true}}],"security":"SSKN Common Stock","published_at":"2022-03-28T17:03:51.000Z","date":"2022-03-25","kind":"purchase","acquired":true,"shares":16950,"price":1.7336,"value":29384.52,"ownership":{"direct":true},"balance_after":484440,"source":{"system":"sec-edgar","filing":"0001051514-22-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000105151422000035/form4.xml","form_type":"4"}},{"id":2319107,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true}}],"security":"SSKN Common Stock","published_at":"2022-03-24T20:32:28.000Z","date":"2022-03-24","kind":"purchase","acquired":true,"shares":14783,"price":1.582,"value":23386.706,"ownership":{"direct":true},"balance_after":467490,"source":{"system":"sec-edgar","filing":"0001051514-22-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000105151422000033/form4.xml","form_type":"4"}},{"id":2437768,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-11T21:45:35.000Z","date":"2022-01-10","kind":"exercise","acquired":false,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.15,"expiration_date":"2022-01-30","underlying":"Common Stock","underlying_shares":22727},"source":{"system":"sec-edgar","filing":"0001209191-22-002893","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919122002893/doc4.xml","form_type":"4"}},{"id":2437767,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-11T21:45:35.000Z","date":"2022-01-10","kind":"exercise","acquired":true,"shares":22727,"price":0.15,"value":3409.05,"ownership":{"direct":true},"balance_after":28313,"source":{"system":"sec-edgar","filing":"0001209191-22-002893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919122002893/doc4.xml","form_type":"4"}},{"id":2569712,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2021-09-15T08:15:34.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal monthly installments over 36 months from September 14, 2021, subject to the reporting person's continued service through each such date."}],"balance_after":28000,"derivative":{"exercise_price":2.8,"expiration_date":"2031-09-14","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001169245-21-000097","document":"wf-form4_163170811314129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000097/wf-form4_163170811314129.xml","form_type":"4"}},{"id":2593846,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true}}],"security":"Non-Qualified Stock Option Agreement for SSKN Common Stock","published_at":"2021-08-23T16:44:01.000Z","date":"2021-08-20","kind":"grant","acquired":true,"shares":411124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options vest, commensing on the first anniversary, in equal annual installments, over a 4 year period."}],"balance_after":452707,"derivative":{"exercise_price":1.42,"exercise_date":"2022-08-20","expiration_date":"2031-08-20","underlying":"Common Stock","underlying_shares":411124},"source":{"system":"sec-edgar","filing":"0001051514-21-000057","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000105151421000057/form4.xml","form_type":"4"}},{"id":2628468,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true}}],"security":"SSKN Common Stock","published_at":"2021-07-21T17:28:01.000Z","date":"2021-07-20","kind":"grant","acquired":true,"shares":21583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents Restricted Stock Units issued to the recipient, in lieu of a portion of the recipient's Board Compensation, on July 20, 2021. The Restricted Stock Units generally vest at 100% on the first anniversary of the date of grant.  RSUs have a minimum one year vesting unless as permitted under Section 7.3(c)."}],"balance_after":41583,"source":{"system":"sec-edgar","filing":"0001051514-21-000034","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000105151421000034/form4.xml","form_type":"4"}},{"id":2628467,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true}}],"security":"SSKN Common Stock","published_at":"2021-07-21T17:28:01.000Z","date":"2021-07-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Restricted Stock Units issued to the recipient, per the Director Compensation Program relating to recipient becoming a board member. The Restricted Stock Units generally vest 100% on the first anniversary date.  RSUs have a minimum one year vesting unless as permitted under Section 7.3(c)."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001051514-21-000034","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000105151421000034/form4.xml","form_type":"4"}},{"id":2671989,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T21:35:16.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 10, 2022."}],"balance_after":25000,"derivative":{"exercise_price":3.11,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-039953","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919121039953/doc4.xml","form_type":"4"}},{"id":2680972,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-04T23:57:34.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":3356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date."}],"balance_after":3356,"derivative":{"underlying":"Common Stock","underlying_shares":3356},"source":{"system":"sec-edgar","filing":"0001209191-21-038446","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919121038446/doc4.xml","form_type":"4"}},{"id":2680971,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T23:57:34.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":12250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject this option will vest in twelve equal monthly installments commencing July 3, 2021, subject to Reporting Person's continuous service through each such date."}],"balance_after":12250,"derivative":{"exercise_price":21.9,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":12250},"source":{"system":"sec-edgar","filing":"0001209191-21-038446","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919121038446/doc4.xml","form_type":"4"}},{"id":2954273,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Non-qualified Stock Options (right To Purchase)","published_at":"2020-12-08T21:23:38.000Z","date":"2020-12-04","kind":"exercise","acquired":false,"shares":114055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":14.38,"expiration_date":"2027-03-01","underlying":"Common Shares, No Par Value","underlying_shares":114055},"source":{"system":"sec-edgar","filing":"0001127602-20-030840","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220030840/form4.xml","form_type":"4"}},{"id":2954272,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Shares, No Par Value","published_at":"2020-12-08T21:23:38.000Z","date":"2020-12-04","kind":"sale","acquired":false,"shares":114055,"price":19.8711,"value":2266398.3105,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $19.80 to $19.82 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote."}],"balance_after":235035,"source":{"system":"sec-edgar","filing":"0001127602-20-030840","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220030840/form4.xml","form_type":"4"}},{"id":2954271,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Shares, No Par Value","published_at":"2020-12-08T21:23:38.000Z","date":"2020-12-04","kind":"exercise","acquired":true,"shares":114055,"price":14.38,"value":1640110.9,"ownership":{"direct":true},"balance_after":349090,"source":{"system":"sec-edgar","filing":"0001127602-20-030840","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220030840/form4.xml","form_type":"4"}},{"id":2964758,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Non-qualified Stock Options (right To Purchase)","published_at":"2020-11-30T21:50:11.000Z","date":"2020-11-27","kind":"exercise","acquired":false,"shares":13663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":114055,"derivative":{"exercise_price":14.38,"expiration_date":"2027-03-01","underlying":"Common Shares, No Par Value","underlying_shares":13663},"source":{"system":"sec-edgar","filing":"0001127602-20-030120","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220030120/form4.xml","form_type":"4"}},{"id":2964757,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Non-qualified Stock Options (right To Purchase)","published_at":"2020-11-30T21:50:11.000Z","date":"2020-11-24","kind":"exercise","acquired":false,"shares":21658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":127718,"derivative":{"exercise_price":14.38,"expiration_date":"2027-03-01","underlying":"Common Shares, No Par Value","underlying_shares":21658},"source":{"system":"sec-edgar","filing":"0001127602-20-030120","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220030120/form4.xml","form_type":"4"}},{"id":2964756,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Non-qualified Stock Options (right To Purchase)","published_at":"2020-11-30T21:50:11.000Z","date":"2020-11-23","kind":"exercise","acquired":false,"shares":1483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":149376,"derivative":{"exercise_price":14.38,"expiration_date":"2027-03-01","underlying":"Common Shares, No Par Value","underlying_shares":1483},"source":{"system":"sec-edgar","filing":"0001127602-20-030120","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220030120/form4.xml","form_type":"4"}},{"id":2964755,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Shares, No Par Value","published_at":"2020-11-30T21:50:11.000Z","date":"2020-11-27","kind":"sale","acquired":false,"shares":13663,"price":19.6302,"value":268207.4226,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $19.63 to $19.635 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote."}],"balance_after":235035,"source":{"system":"sec-edgar","filing":"0001127602-20-030120","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220030120/form4.xml","form_type":"4"}},{"id":2964754,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Shares, No Par Value","published_at":"2020-11-30T21:50:11.000Z","date":"2020-11-27","kind":"exercise","acquired":true,"shares":13663,"price":14.38,"value":196473.94,"ownership":{"direct":true},"balance_after":248698,"source":{"system":"sec-edgar","filing":"0001127602-20-030120","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220030120/form4.xml","form_type":"4"}},{"id":2964753,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Shares, No Par Value","published_at":"2020-11-30T21:50:11.000Z","date":"2020-11-24","kind":"sale","acquired":false,"shares":21658,"price":19.6323,"value":425196.3534,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $19.63 to $19.66 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote."}],"balance_after":235035,"source":{"system":"sec-edgar","filing":"0001127602-20-030120","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220030120/form4.xml","form_type":"4"}},{"id":2964752,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Shares, No Par Value","published_at":"2020-11-30T21:50:11.000Z","date":"2020-11-23","kind":"sale","acquired":false,"shares":1483,"price":19.6328,"value":29115.4424,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $19.63 to $19.64 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote."}],"balance_after":235035,"source":{"system":"sec-edgar","filing":"0001127602-20-030120","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220030120/form4.xml","form_type":"4"}},{"id":2964751,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Shares, No Par Value","published_at":"2020-11-30T21:50:11.000Z","date":"2020-11-24","kind":"exercise","acquired":true,"shares":21658,"price":14.38,"value":311442.04,"ownership":{"direct":true},"balance_after":258176,"source":{"system":"sec-edgar","filing":"0001127602-20-030120","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220030120/form4.xml","form_type":"4"}},{"id":2964750,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Shares, No Par Value","published_at":"2020-11-30T21:50:11.000Z","date":"2020-11-23","kind":"exercise","acquired":true,"shares":1483,"price":14.38,"value":21325.54,"ownership":{"direct":true},"balance_after":236518,"source":{"system":"sec-edgar","filing":"0001127602-20-030120","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220030120/form4.xml","form_type":"4"}},{"id":3034821,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Shares, No Par Value","published_at":"2020-09-10T20:34:44.000Z","date":"2020-09-08","kind":"sale","acquired":false,"shares":5667,"price":16.17,"value":91635.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person."}],"balance_after":235035,"source":{"system":"sec-edgar","filing":"0001127602-20-024896","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220024896/form4.xml","form_type":"4"}},{"id":3052973,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Shares, No Par Value","published_at":"2020-08-19T23:12:52.000Z","date":"2020-08-17","kind":"tax_withholding","acquired":false,"shares":4567,"price":17.48,"value":79831.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":240702,"source":{"system":"sec-edgar","filing":"0001127602-20-023930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220023930/form4.xml","form_type":"4"}},{"id":3054408,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-18T23:53:34.000Z","date":"2020-08-18","kind":"purchase","acquired":true,"shares":5586,"price":1.78,"value":9943.08,"ownership":{"direct":true},"balance_after":5586,"source":{"system":"sec-edgar","filing":"0001209191-20-047348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919120047348/doc4.xml","form_type":"4"}},{"id":3104342,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-19T20:36:23.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 18, 2021."}],"balance_after":25000,"derivative":{"exercise_price":2,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-037947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919120037947/doc4.xml","form_type":"4"}},{"id":3118730,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-08T21:29:21.000Z","date":"2020-06-06","kind":"exercise","acquired":false,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"shares","element":"transactionShares","label":"F3","text":"This grant was made pursuant to the issuer's amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units vested on June 6, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units vested on June 6, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7333},"source":{"system":"sec-edgar","filing":"0001209191-20-035032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919120035032/doc4.xml","form_type":"4"}},{"id":3118729,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option Grant (right to buy)","published_at":"2020-06-08T21:29:21.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject this option will vest in twelve equal monthly installments commencing July 4, 2020, subject to Reporting Person's continuous service through each such date."}],"balance_after":16500,"derivative":{"exercise_price":1.41,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-20-035032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919120035032/doc4.xml","form_type":"4"}},{"id":3118728,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T21:29:21.000Z","date":"2020-06-06","kind":"exercise","acquired":true,"shares":7333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":16209,"source":{"system":"sec-edgar","filing":"0001209191-20-035032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919120035032/doc4.xml","form_type":"4"}},{"id":3227648,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2020-03-04T21:24:40.000Z","date":"2020-03-02","kind":"exercise","acquired":false,"shares":8876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying these restricted stock units vest immediately."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying these restricted stock units vest immediately."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8876},"source":{"system":"sec-edgar","filing":"0001209191-20-016078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919120016078/doc4.xml","form_type":"4"}},{"id":3227647,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2020-03-04T21:24:40.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":8876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying these restricted stock units vest immediately."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying these restricted stock units vest immediately."}],"balance_after":8876,"derivative":{"underlying":"Common Stock","underlying_shares":8876},"source":{"system":"sec-edgar","filing":"0001209191-20-016078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919120016078/doc4.xml","form_type":"4"}},{"id":3227646,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-04T21:24:40.000Z","date":"2020-03-02","kind":"exercise","acquired":true,"shares":8876,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":8876,"source":{"system":"sec-edgar","filing":"0001209191-20-016078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919120016078/doc4.xml","form_type":"4"}},{"id":3235077,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Shares, No Par Value","published_at":"2020-03-03T22:26:54.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":2264,"price":24.44,"value":55332.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":245269,"source":{"system":"sec-edgar","filing":"0001127602-20-009139","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220009139/form4.xml","form_type":"4"}},{"id":3242183,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Non-qualified Stock Options (right To Purchase)","published_at":"2020-02-29T00:28:54.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":56858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":56858,"derivative":{"exercise_price":24.77,"expiration_date":"2030-02-26","underlying":"Common Shares, No Par Value","underlying_shares":56858},"source":{"system":"sec-edgar","filing":"0001127602-20-008444","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220008444/form4.xml","form_type":"4"}},{"id":3242182,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Shares, No Par Value","published_at":"2020-02-29T00:28:54.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":13506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value (\"Common Shares\"), of Bausch Health Companies Inc. (\"Bausch Health\")."}],"balance_after":247533,"source":{"system":"sec-edgar","filing":"0001127602-20-008444","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220008444/form4.xml","form_type":"4"}},{"id":3254615,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Restricted Share Units","published_at":"2020-02-25T01:54:14.000Z","date":"2020-02-19","kind":"exercise","acquired":false,"shares":20911,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 2, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 2, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This PSU award was previously reported on a Form 4 filed on January 4, 2017 with the maximum potential award amount of 41,002 shares. Any portion of the award not vested on February 19, 2020 was cancelled as of that date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20911},"source":{"system":"sec-edgar","filing":"0001127602-20-007430","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220007430/form4.xml","form_type":"4"}},{"id":3254614,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Stock, No Par Value","published_at":"2020-02-25T01:54:14.000Z","date":"2020-02-20","kind":"tax_withholding","acquired":false,"shares":56532,"price":26.46,"value":1495836.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs."}],"balance_after":234027,"source":{"system":"sec-edgar","filing":"0001127602-20-007430","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220007430/form4.xml","form_type":"4"}},{"id":3254613,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Stock, No Par Value","published_at":"2020-02-25T01:54:14.000Z","date":"2020-02-19","kind":"grant","acquired":true,"shares":105783,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":290559,"source":{"system":"sec-edgar","filing":"0001127602-20-007430","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220007430/form4.xml","form_type":"4"}},{"id":3254612,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Stock, No Par Value","published_at":"2020-02-25T01:54:14.000Z","date":"2020-02-19","kind":"exercise","acquired":true,"shares":20911,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects common shares, no par value (\"Common Shares\") of Bausch Health Companies Inc. (the \"Company\") issued to the reporting person in connection with the vesting of performance-based Restricted Share Units (\"PSUs\") granted to the reporting person on January 2, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 2, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each PSU converts into Common Shares on a one-for-one basis."}],"balance_after":184776,"source":{"system":"sec-edgar","filing":"0001127602-20-007430","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220007430/form4.xml","form_type":"4"}},{"id":3316941,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Stock, No Par Value","published_at":"2020-01-07T21:18:43.000Z","date":"2020-01-03","kind":"tax_withholding","acquired":false,"shares":14559,"price":29.92,"value":435605.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":163865,"source":{"system":"sec-edgar","filing":"0001127602-20-001277","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220001277/form4.xml","form_type":"4"}},{"id":3433633,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Stock, No Par Value","published_at":"2019-08-20T20:17:31.000Z","date":"2019-08-16","kind":"grant","acquired":true,"shares":30703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents matching Restricted Share Units (\"MRSUs\") granted to the Reporting Person in connection with the open market purchase of Common Shares of the Issuer reported on Table I (the \"Purchased Shares\"), pursuant to the Issuer's Matching Share Program.  One-third of the MRSUs will vest on each of the first, second and third anniversaries following the date of grant (\"MRSU Grant Date\"), subject to the Reporting Person's continued service (except in limited circumstances)."}],"balance_after":178424,"source":{"system":"sec-edgar","filing":"0001127602-19-027064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219027064/form4.xml","form_type":"4"}},{"id":3433632,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Stock, No Par Value","published_at":"2019-08-20T20:17:31.000Z","date":"2019-08-16","kind":"purchase","acquired":true,"shares":30703,"price":21.1752,"value":650142.1656,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $21.13 to $21.18 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote."}],"balance_after":147721,"source":{"system":"sec-edgar","filing":"0001127602-19-027064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219027064/form4.xml","form_type":"4"}},{"id":3480140,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-24T20:26:33.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next meeting of stockholders or June 20, 2020."}],"balance_after":20000,"derivative":{"exercise_price":1.07,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-038770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919119038770/doc4.xml","form_type":"4"}},{"id":3495775,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-10T20:56:09.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was made pursuant to the issuer's amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying these restricted stock units vest on June 6, 2020, subject to the Reporting Person's continuous service with the issuer as of the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying these restricted stock units vest on June 6, 2020, subject to the Reporting Person's continuous service with the issuer as of the vesting date."}],"balance_after":7333,"derivative":{"underlying":"Common Stock","underlying_shares":7333},"source":{"system":"sec-edgar","filing":"0001209191-19-035840","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919119035840/doc4.xml","form_type":"4"}},{"id":3624661,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Non-qualified Stock Options (right To Purchase)","published_at":"2019-03-01T22:11:11.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":44290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":44290,"derivative":{"exercise_price":23.16,"expiration_date":"2029-02-27","underlying":"Common Shares, No Par Value","underlying_shares":44290},"source":{"system":"sec-edgar","filing":"0001127602-19-009252","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219009252/form4.xml","form_type":"4"}},{"id":3624660,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Stock, No Par Value","published_at":"2019-03-01T22:11:11.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":15221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value (\"Common Shares\"), of Bausch Health Companies Inc. (\"Bausch Health\")."}],"balance_after":117018,"source":{"system":"sec-edgar","filing":"0001127602-19-009252","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219009252/form4.xml","form_type":"4"}},{"id":3702517,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"President, Ortho-Dermatologics"}}],"security":"Common Stock, No Par Value","published_at":"2019-01-07T21:22:07.000Z","date":"2019-01-03","kind":"tax_withholding","acquired":false,"shares":13311,"price":18.47,"value":245854.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":101797,"source":{"system":"sec-edgar","filing":"0001127602-19-001498","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219001498/form4.xml","form_type":"4"}},{"id":3886161,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-21T21:19:36.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 20, 2019."}],"balance_after":11250,"derivative":{"exercise_price":10.74,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001209191-18-038983","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919118038983/doc4.xml","form_type":"4"}},{"id":3900098,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-08T20:01:21.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in twelve equal monthly installments through June 7, 2019, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":8000,"derivative":{"exercise_price":18.35,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-18-036650","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919118036650/doc4.xml","form_type":"4"}},{"id":4106048,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"officer":true,"officer_title":"EVP, COMPANY GROUP CHAIRMAN"}}],"security":"Common Stock, No Par Value","published_at":"2018-01-05T20:58:53.000Z","date":"2018-01-03","kind":"tax_withholding","acquired":false,"shares":14730,"price":20.78,"value":306089.4,"ownership":{"direct":true},"balance_after":115108,"source":{"system":"sec-edgar","filing":"0001127602-18-001241","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218001241/form4.xml","form_type":"4"}},{"id":4264673,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-05T22:05:04.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":2632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 30, 2018."}],"balance_after":2632,"derivative":{"exercise_price":9.11,"expiration_date":"2027-06-29","underlying":"Common Stock","underlying_shares":2632},"source":{"system":"sec-edgar","filing":"0001209191-17-043402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919117043402/doc4.xml","form_type":"4"}},{"id":4273570,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-23T20:38:00.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":8618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2018."}],"balance_after":8618,"derivative":{"exercise_price":8.81,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":8618},"source":{"system":"sec-edgar","filing":"0001209191-17-041676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919117041676/doc4.xml","form_type":"4"}},{"id":4279189,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-16T23:46:06.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in twelve equal monthly installments through June 15, 2018, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":8000,"derivative":{"exercise_price":24.58,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-17-040673","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674278/000120919117040673/doc4.xml","form_type":"4"}},{"id":4406593,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COMPANY GROUP CHAIRMAN"}}],"security":"Non-Qualified Stock Options (right to purchase)","published_at":"2017-03-03T22:51:17.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":150859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":150859,"derivative":{"exercise_price":14.38,"expiration_date":"2027-03-01","underlying":"Common Shares, no par value","underlying_shares":150859},"source":{"system":"sec-edgar","filing":"0001681871-17-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000168187117000008/primary_doc.xml","form_type":"4"}},{"id":4504971,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Company Group Chairman"}}],"security":"Restricted Share Units","published_at":"2017-01-05T01:41:10.000Z","date":"2017-01-02","kind":"grant","acquired":true,"shares":41002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents a grant of performance-based RSUs.  The target number of performance-based RSUs granted to the reporting person was 20,501 and the maximum number that can be distributed is 41,002.  The performance-based RSUs shall vest and be distributed between 0-200% of target based on Valeant's Total Shareholder Return (\"TSR\") as measured on January 2, 2020 (the \"Measurement Date\").  If Valeant's TSR for the period between the grant date and the Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a grant of performance-based RSUs.  The target number of performance-based RSUs granted to the reporting person was 20,501 and the maximum number that can be distributed is 41,002.  The performance-based RSUs shall vest and be distributed between 0-200% of target based on Valeant's Total Shareholder Return (\"TSR\") as measured on January 2, 2020 (the \"Measurement Date\").  If Valeant's TSR for the period between the grant date and the Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award."}],"balance_after":41002,"derivative":{"expiration_date":"2020-01-02","underlying":"Common Stock","underlying_shares":41002},"source":{"system":"sec-edgar","filing":"0001674278-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000167427817000004/primary_doc.xml","form_type":"4"}},{"id":4504970,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40485,"kind":"person","name":"Humphries William D.","position":1,"cik":"0001674278","reported_name":"Humphries William D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Company Group Chairman"}}],"security":"Common Stock, no par value","published_at":"2017-01-05T01:41:10.000Z","date":"2017-01-02","kind":"grant","acquired":true,"shares":129838,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of Restricted Share Units (\"RSUs\") which will vest one-third on each of the three anniversaries following the date of grant, subject to the reporting person's continued service subject to continued service. Vested RSUs are settled in common shares, no par value (\"Common Shares\"), of Valeant Pharmaceuticals International, Inc. (\"Valeant\")."}],"balance_after":129838,"source":{"system":"sec-edgar","filing":"0001674278-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000167427817000004/primary_doc.xml","form_type":"4"}}]}